Your browser doesn't support javascript.
loading
Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains.
Stanojevic, Maja; Geiger, Ashley; Ostermeier, Brita; Sohai, Danielle; Lazarski, Christopher; Lang, Haili; Jensen-Wachspress, Mariah; Webber, Kathleen; Burbelo, Peter; Cohen, Jeffrey; Keller, Michael D; Bollard, Catherine M; Cruz, Conrad Russell Y.
Affiliation
  • Stanojevic M; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Geiger A; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Ostermeier B; Institute for Biomedical Sciences, George Washington University, Washington, DC, USA.
  • Sohai D; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Lazarski C; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Lang H; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Jensen-Wachspress M; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Webber K; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Burbelo P; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
  • Cohen J; National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
  • Keller MD; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Bollard CM; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA. Electronic address: cbollard@childrensnational.org.
  • Cruz CRY; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA. Electronic address: ccruz@childrensnational.org.
Cytotherapy ; 24(1): 10-15, 2022 01.
Article in En | MEDLINE | ID: mdl-34483067
ABSTRACT
Although most studies describing coronavirus disease 2019 vaccine responses have focused on antibodies, there is increasing evidence that T cells play a critical role. Here the authors evaluated T-cell responses in seronegative donors before and after vaccination to define responses to the severe acute respiratory syndrome coronavirus 2 reference strain as well as to mutations in the variant strains Alpha/B.1.1.7 and Beta/B.1.351. The authors observed enhanced T-cell responses to reference and variant spike strains post-vaccination.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Cytotherapy Journal subject: TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Cytotherapy Journal subject: TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Estados Unidos
...